Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to determine the effectiveness of the NESS L300 (L300) in improving gait parameters, function, and quality of life among stroke subjects (greater than or equal to 3 months post stroke)with drop foot.


Clinical Trial Description

Approximately 176 subjects with stroke that have drop foot will be enrolled from approximately 10 different sites in the United States depending on the rate of enrollment. This clinical study is proposed to show that the FES delivered via the L300 improves gait function, stroke-specific quality of life, and safety for persons with stroke. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01138995
Study type Interventional
Source Bioness Inc
Contact
Status Completed
Phase Phase 4
Start date May 2010
Completion date February 2013

See also
  Status Clinical Trial Phase
Recruiting NCT04607174 - Voluntary Activation During Isokinetic Contractions in Subjects With Neuromotor Disorders N/A
Recruiting NCT05778474 - Mechanical Determinants of Upper Limbs Oscillation During Gait
Completed NCT02404857 - BCI Post-stroke Neurorehabilitation N/A
Recruiting NCT04635436 - Efficacy of Split Gait in the Treatment of Dynamic Asymmetries in Subjects With Pathologic Claudication
Withdrawn NCT03230370 - Does the Enhanced Rehabilitation Programs Facilitate the Motor Recovery After Stroke? N/A